Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial.

MLA

Salmon-Céron, Dominique, et al. “Interferon-Ribavirin in Association with Stavudine Has No Impact on Plasma Human Immunodeficiency Virus (HIV) Type 1 Level in Patients Coinfected with HIV and Hepatitis C Virus: A CORIST-ANRS HC1 Trial.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 36, no. 10, May 2003, pp. 1295–304. EBSCOhost, https://doi.org/10.1086/374837.

APA

Salmon-Céron, D., Lassalle, R., Pruvost, A., Benech, H., Bouvier-Alias, M., Payan, C., Goujard, C., Bonnet, E., Zoulim, F., Morlat, P., Sogni, P., Pérusat, S., Tréluyer, J.-M., & Chêne, G. (2003). Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 36(10), 1295–1304. https://doi.org/10.1086/374837

Chicago

Salmon-Céron, Dominique, Régis Lassalle, Alain Pruvost, Henri Benech, Magali Bouvier-Alias, Christopher Payan, Cécile Goujard, et al. 2003. “Interferon-Ribavirin in Association with Stavudine Has No Impact on Plasma Human Immunodeficiency Virus (HIV) Type 1 Level in Patients Coinfected with HIV and Hepatitis C Virus: A CORIST-ANRS HC1 Trial.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 36 (10): 1295–1304. doi:10.1086/374837.